2023
Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review
Cooper D, Ramachandra R, Ceban F, Di Vincenzo J, Rhee T, Mansur R, Teopiz K, Gill H, Ho R, Cao B, Lui L, Jawad M, Arsenault J, Le G, Ramachandra D, Guo Z, McIntyre R. Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review. Journal Of Psychiatric Research 2023, 164: 80-89. PMID: 37331261, DOI: 10.1016/j.jpsychires.2023.05.041.Peer-Reviewed Original ResearchMeSH KeywordsDepressionDiabetes Mellitus, Type 2Glucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorHumansHypoglycemic AgentsProtective FactorsRetrospective StudiesConceptsGLP-1 receptor agonistsGlucagon-like peptide-1 receptor agonistsPeptide-1 receptor agonistsIncident depressionDiabetes mellitusReceptor agonistType 2 diabetes mellitusRetrospective observational studyPubMed/MEDLINEEnglish-language articlesHigh interstudy heterogeneityGoogle Scholar databasesPaucity of literatureGlycemic controlNeuroprotective effectsAntidepressant propertiesNeuroprotective potentialInterstudy heterogeneityObservational studyPatientsSystematic reviewAgonistsMellitusScholar databasesProtective factors
2021
Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: A systematic review and meta-analysis
Liu YK, Ling S, Lui LMW, Ceban F, Vinberg M, Kessing LV, Ho RC, Rhee TG, Gill H, Cao B, Mansur RB, Lee Y, Rosenblat J, Teopiz KM, McIntyre RS. Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: A systematic review and meta-analysis. Journal Of Affective Disorders 2021, 300: 449-461. PMID: 34965395, DOI: 10.1016/j.jad.2021.12.110.Peer-Reviewed Original ResearchMeSH KeywordsBipolar DisorderBlood GlucoseDiabetes Mellitus, Type 2FastingGlucoseHumansObesityObesity, AbdominalPrevalenceConceptsType 2 diabetes mellitusAbdominal obesityGeneral obesityNewcastle-Ottawa ScaleGender-matched controlsDiabetes mellitusBipolar disorderGender-matched healthy controlsPrevalence of T2DMRisk of obesityCase-control studyTimes greater riskPooled prevalenceLanguage restrictionsPlasma glucoseHealthy controlsHigh prevalenceSources of heterogeneityInclusion criteriaMethodological qualityObesityPatientsT2DMSystematic reviewGreater risk